Cohort 2024↗
Augment Biologics
Using foundational discoveries in glycobiology to transform biologic drug development.
← All companies
Cohort 2024
Voyant Bio
Designing precision immunotherapies targeting immune-immune cell interactions to radically improve cancer patient treatment outcomes.
Part of the Studio communityCohort 2024
Keep exploring
More from this cohort.
Cohort 2024↗
Esya
Making brain health screening as routine and accessible as any other essential health check.
Cohort 2024↗
Hebbian Bio
Unlocking novel treatments and biomarkers for neuro conditions through precision medicine.
Connect with MDSS
Your next step starts
with a conversation.
Building a company, exploring the program or looking to contribute? Tell us what you have in mind.
Let’s talk Founders · Partners · Mentors